Printer Friendly

Browse Irinotecan topic

Articles

1-25 out of 25 article(s)
Title Author Type Date Words
Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients. Imai, Hiroo; Saijo, Ken; Komine, Keigo; Yoshida, Yuya; Sasaki, Keiju; Suzuki, Asako; Ouchi, Kota; Ta Jun 30, 2020 4975
Ipsen and Servier Present Initial Phase II/III Clinical Data Evaluating Investigational Liposomal Irinotecan (Onivyde) as a Second-Line Treatment for Small Cell Lung Cancer. Sep 9, 2019 553
Ipsen and Servier Release Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer. Jul 9, 2019 509
Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism. Jannin, Arnaud; Hennart, Benjamin; Adenis, Antoine; Chauffert, Bruno; Penel, Nicolas Clinical report Jan 1, 2017 1980
Establishment of a Novel Model for Anticancer Drug Resistance in Three- Dimensional Primary Culture of Tumor Microenvironment. Usui, Tatsuya; Sakurai, Masashi; Enjoji, Shuhei; Kawasaki, Hideyoshi; Umata, Koji; Ohama, Takashi; F Report Jan 1, 2017 4313
Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats. Deng, Chao; Deng, Bo; Jia, Liqun; Tan, Huangying; Zhang, Pan; Liu, Sida; Zhang, Yanan; Song, Aiping; Jan 1, 2017 6727
Sagent Pharmaceuticals Inc unveils Irinotecan Injection in single dose vials. May 18, 2012 147
Sagent Pharmaceuticals Inc unveils Irinotecan Injection in single dose vials. May 18, 2012 133
Alvogen introduces generic versions of three oncology products in Romania. Aug 12, 2011 241
Camptothecins and their novel anticancer properties evaluated by using pass method. Behrangi, N.; Hashemi, M.; Doustar, Y.; Borna H. Report Aug 1, 2011 2184
Pipeline remains productive. Nov 24, 2008 433
A randomized Phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer. Gullen-Ponce, Carmen; Carrato, Alfredo Report Sep 1, 2008 762
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies. Labianca, Roberto Clinical report Sep 1, 2008 494
Generics makers keep new products coming. Apr 28, 2008 668
Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. Van Cutsem, Eric Mar 1, 2008 642
Irinotecan-containing therapy in elderly patients with metastatic colorectal cancer. Folprecht, Gunnar Clinical report Dec 1, 2007 2052
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil. Kohne, Claus-Henning Sep 1, 2007 545
A phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine. Rougier, Philippe Sep 1, 2007 683
Epidermal growth factor receptor-targeted therapies in colorectal cancer. Hamdulay, Parvez Jun 1, 2007 3611
A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Montenegro-Beltran, Paola; Carrato, Alfredo Jun 1, 2007 1398
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of a randomised phase II study. Kohne, Claus-Henning Jun 1, 2007 507
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. Van Cutsem, Eric Jun 1, 2007 438
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment. Labianca, Roberto Jun 1, 2007 422
Medicare: some cancer drugs to be covered for off-label use in trials. Frieden, Joyce Brief Article Dec 1, 2005 220
Irinotecan label should include genotype data. Ault, Alicia Dec 15, 2004 717

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters